Referencias bibliográficas

1. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb;17(2):162-73. [Pubmed]
2. Hartung HP, Graf J, Aktas O, Mares J, Barnett MH. Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and change. Curr Opin Neurol. 2019 Jun;32(3):327-37. [Pubmed]
3. Schwenkenbecher P, Wurster U, Konen FF, Gingele S, Sühs KW, Wattjes MP, et al. Impact of the McDonald Criteria 2017 on Early Diagnosis of Relapsing-Remitting Multiple Sclerosis. Front Neurol. 2019 Mar 15;10:188. [Pubmed]
4. Solomon AJ. Diagnosis, Differential Diagnosis, and Misdiagnosis of Multiple Sclerosis. Continuum (Minneap Minn). 2019 Jun;25(3):611-35. [Pubmed]
5. Rovira À, Wattjes MP, Tintoré M, Tur C, Yousry TA, Sormani MP, et al.; MAGNIMS study group. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol. 2015 Aug;11(8):471-82. Erratum in: Nat Rev Neurol. 2015 Aug;11(8):483. [Pubmed]
6. Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, et al.; MAGNIMS Study Group. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol. 2016 Mar;15(3):292-303. [Pubmed]
7. Traboulsee A, Simon JH, Stone L, Fisher E, Jones DE, Malhotra A, et al. Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis. AJNR Am J Neuroradiol. 2016 Mar;37(3):394-401. [Pubmed]
8. Wattjes MP, Ciccarelli O, Reich DS, Banwell B, de Stefano N, Enzinger C, et al.; Magnetic Resonance Imaging in Multiple Sclerosis study group; Consortium of Multiple Sclerosis Centres; North American Imaging in Multiple Sclerosis Cooperative MRI guidelines working group. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol. 2021 Aug;20(8):653-70. [Pubmed]
9. Chen Y, Haacke EM, Bernitsas E. Imaging of the Spinal Cord in Multiple Sclerosis: Past, Present, Future. Brain Sci. 2020 Nov 13;10(11):857. [Pubmed]
10. Etemadifar M, Ashourizadeh H, Nouri H, Kargaran PK, Salari M, Rayani M, et al. MRI signs of CNS demyelinating diseases. Mult Scler Relat Disord. 2021 Jan;47:102665. [Pubmed]
11. Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain. 2019 Jul 1;142(7):1858-75. [Pubmed]
12. Paoletti M, Muzic SI, Marchetti F, Farina LM, Bastianello S, Pichiecchio A. Differential imaging of atypical demyelinating lesions of the central nervous system. Radiol Med. 2021 Jun;126(6):827-42. [Pubmed]
13. Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, et al.; MAGNIMS study group. The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol. 2018 Apr;14(4):199-213. Erratum in: Nat Rev Neurol. 2018 Mar 20;14 (4):213. [Pubmed]
14. Bouman PM, Steenwijk MD, Pouwels PJW, Schoonheim MM, Barkhof F, Jonkman LE, Geurts JJG. Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis. Brain. 2020 Oct 1;143(10):2988-97. [Pubmed]
15. Wildner P, Stasiołek M, Matysiak M. Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases. Mult Scler Relat Disord. 2020 Jan;37:101452. [Pubmed]
16. Kuchling J, Paul F. Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Front Neurol. 2020 Jun 17;11:450. [Pubmed]
17. Weidauer S, Raab P, Hattingen E. Diagnostic approach in multiple sclerosis with MRI: an update. Clin Imaging. 2021 Oct;78:276-85. [Pubmed]
18. Matthews L, Marasco R, Jenkinson M, Küker W, Luppe S, Leite MI, et al. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology. 2013 Apr 2;80(14):1330-7 [Pubmed]
19. Marignier R, Hacohen Y, Cobo-Calvo A, Pröbstel AK, Aktas O, Alexopoulos H, et al. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021 Sep;20(9):762-72. Erratum in: Lancet Neurol. 2021 Oct;20(10):e6. Erratum in: Lancet Neurol. 2022 Jan;21(1):e1. [Pubmed]
20. Haralur Y, Mechtler LL. Neuroimaging of Multiple Sclerosis Mimics. Neurol Clin. 2020 Feb;38(1):149-70. [Pubmed]
21. Cortese R, Collorone S, Ciccarelli O, Toosy AT. Advances in brain imaging in multiple sclerosis. Ther Adv Neurol Disord. 2019 Jun 27;12:1756286419859722. [Pubmed]
22. Preziosa P, Rocca MA, Filippi M. Central vein sign and iron rim in multiple sclerosis: ready for clinical use? Curr Opin Neurol. 2021 Aug 1;34(4):505-13. [Pubmed]
23. Castellaro M, Tamanti A, Pisani AI, Pizzini FB, Crescenzo F, Calabrese M. The Use of the Central Vein Sign in the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-analysis. Diagnostics (Basel). 2020 Nov 29;10(12):1025. [Pubmed]
24. Inglese M, Petracca M. MRI in multiple sclerosis: clinical and research update. Curr Opin Neurol. 2018 Jun;31(3):249-55. [Pubmed]
25. Sastre-Garriga J, Pareto D, Battaglini M, Rocca MA, Ciccarelli O, Enzinger C, et al.; MAGNIMS study group. MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nat Rev Neurol. 2020 Mar;16(3):171-82. [Pubmed]